Congratulations to the lab who has received an award of $225,000 for 2 years from the Lisa Dean Moseley Foundation for their proposed research on cellular therapy for knee osteoarthritis.
Stem cell therapy is a rapidly evolving treatment for osteoarthritis that has been employed despite proper evidence to support its application. There is a paucity of high-level evidence publications supporting stem cell use for early osteoarthritis and although stem cell therapy has largely been shown to be safe, the literature has not provided a cohesive understanding of patient and cellular characteristics that predict stem cell therapy success. This study will finally demonstrate whether treatment success can be predicted by surveying the interaction between the stem cells and the joint cytokine environment on a cellular and molecular level.
